News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bristol Myers Squibb Company
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Disappointment Over Bristol-Myers Squibb’s Kidney Combo Boosts Bay Area’s Exelixis
August 17, 2017
·
1 min read
Drug Development
Bristol-Myers Squibb’s Stock Topples as Kidney Cancer Drug Flunks Phase III Study
August 16, 2017
·
2 min read
Business
Pharma Giant Bristol-Myers Squibb Plans Layoffs, Effective Oct. 6
August 10, 2017
·
2 min read
Deals
This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb
August 4, 2017
·
3 min read
Job Trends
Seattle Genetics Nabs Bristol-Myers Squibb’s Bothell MFG Facility, Plans to Offer Jobs to Current Employees
August 2, 2017
·
3 min read
Business
Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III
July 31, 2017
·
3 min read
Drug Development
Why AstraZeneca PLC’s MYSTIC Trial Failure May be a Bad Sign for Bristol-Myers Squibb
July 28, 2017
·
2 min read
Policy
Bristol-Myers Squibb Slaps Lawsuit On Biotech Pioneer Genentech Over Cancer Immunotherapy Patents
July 27, 2017
·
1 min read
Drug Development
Bristol-Myers Squibb’s Opdivo Prevails in Phase III Melanoma Trial
July 5, 2017
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
·
10 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Canada Welcomes Positive CDA Recommendation for OPDIVO® Plus YERVOY® as First-Line Treatment for MSI-H/dMMR Metastatic Colorectal Cancer
December 17, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb’s Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
December 12, 2025
·
19 min read
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
·
4 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
·
1 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
·
15 min read
Press Releases
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
December 9, 2025
·
19 min read
Press Releases
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
December 5, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease
December 3, 2025
·
4 min read
